{
    "Trade/Device Name(s)": [
        "VivaChek Ino Blood Glucose Monitoring System",
        "VivaChek Ino Blood Glucose Meter",
        "VivaChek Ino Blood Glucose Test Strips",
        "VivaChek Ino Glucose Control Solution"
    ],
    "Submitter Information": "VivaChek Laboratories, Inc.",
    "510(k) Number": "K160179",
    "Predicate Device Reference 510(k) Number(s)": [
        "K002134",
        "K022769"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "April 7, 2017",
    "Summary Letter Received Date": "April 10, 2017",
    "Submission Date": "December, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single analyte control"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VivaChek Ino Blood Glucose Meter (Model VGM01)"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Glucose oxidase biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for VivaChek Ino Blood Glucose Monitoring System for quantitative measurement of glucose in fresh capillary whole blood using amperometric detection.",
    "Indications for Use Summary": "Intended for single patient home use to quantitatively measure glucose concentration in fresh capillary whole blood from fingertip, forearm, or palm to monitor effectiveness of diabetes control; not for diagnosis, screening, or neonatal use; control solution verifies meter and strip performance.",
    "fda_folder": "Clinical Chemistry"
}